MMP9 and myeloid sarcoma: It degrades myelin constituents (directly or indirectly) in MS pathogenesis in the early stage of the disease, and contributes to remyelination in later stages, as oligodendrocytes might use MMP-9 to facilitate membrane process extensions 24.